We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-4.36%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$97M
AUM Growth
-$3.03M
Cap. Flow
+$3.3M
Cap. Flow %
3.4%
Top 10 Hldgs %
57.24%
Holding
121
New
11
Increased
25
Reduced
53
Closed
27

Top Buys

1
RCM
R1 RCM Inc. Common Stock
RCM
+$8.04M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$796K
3
META icon
Meta Platforms (Facebook)
META
+$581K
4
NVDA icon
NVIDIA
NVDA
+$571K
5
V icon
Visa
V
+$535K

Top Sells

1
GBT
Global Blood Therapeutics, Inc.
GBT
+$5.11M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$456K
3
AAPL icon
Apple
AAPL
+$405K
4
AMZN icon
Amazon
AMZN
+$398K
5
PG icon
Procter & Gamble
PG
+$379K

Sector Composition

1 Healthcare 38.29%
2 Technology 13.92%
3 Financials 11.59%
4 Communication Services 10.86%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
1
CVS Health
CVS
$137B
$10.5M 10.83%
110,238
-725
-0.7% -$71.8K
COR icon
2
Cencora
COR
$59.9B
$8.8M 9.07%
65,023
-1
-0% -$144
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$11.5B
$6.99M 7.21%
82,500
– –
ZBH icon
4
Zimmer Biomet
ZBH
$17.6B
$6.53M 6.73%
62,500
+2,470
+4% +$271K
RCM
5
DELISTED
R1 RCM Inc. Common Stock
RCM
$6.53M 6.73%
+352,500
New +$8.04M
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.22T
$4.42M 4.56%
46,000
– –
APO icon
7
Apollo Global Management
APO
$69.5B
$3.39M 3.5%
72,961
– –
BMRN icon
8
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
$3.39M 3.49%
+40,000
New +$3.56M
MSFT icon
9
Microsoft
MSFT
$2.93T
$2.49M 2.57%
10,695
-481
-4% -$127K
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.23T
$2.47M 2.55%
25,838
+2,358
+10% +$261K
AAPL icon
11
Apple
AAPL
$4.9T
$2.35M 2.42%
16,992
-2,579
-13% -$405K
AMZN icon
12
Amazon
AMZN
$2.66T
$1.95M 2.01%
17,229
-3,151
-15% -$398K
BRK.B icon
13
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.7M 1.75%
6,358
-1,604
-20% -$456K
TSLA icon
14
Tesla
TSLA
$1.43T
$1.28M 1.32%
4,842
-885
-15% -$247K
V icon
15
Visa
V
$682B
$1.21M 1.25%
6,822
+2,627
+63% +$535K
META icon
16
Meta Platforms (Facebook)
META
$1.64T
$1.21M 1.25%
8,914
+3,587
+67% +$581K
PG icon
17
Procter & Gamble
PG
$349B
$1.07M 1.1%
8,453
-2,666
-24% -$379K
MA icon
18
Mastercard
MA
$480B
$1.04M 1.07%
3,649
+1,396
+62% +$463K
NVDA icon
19
NVIDIA
NVDA
$4.91T
$1M 1.03%
82,730
+36,120
+77% +$571K
PEP icon
20
PepsiCo
PEP
$187B
$797K 0.82%
4,879
-1,536
-24% -$265K
ACN icon
21
Accenture
ACN
$87.9B
$780K 0.8%
3,033
+1,053
+53% +$304K
KO icon
22
Coca-Cola
KO
$351B
$779K 0.8%
13,912
-4,387
-24% -$273K
JPM icon
23
JPMorgan Chase
JPM
$907B
$752K 0.77%
7,193
-1,640
-19% -$188K
TEVA icon
24
Teva Pharmaceuticals
TEVA
$37.3B
$726K 0.75%
+90,000
New +$796K
LIN icon
25
Linde
LIN
$237B
$686K 0.71%
2,544
-374
-13% -$107K
1
2 3 4 5

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, DSC Advisors held 121 positions worth $97M, down 3% from $100M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

DSC Advisors deployed $3.3M of net new capital in Q3 2022, opening 11 new positions and adding to 25 existing holdings. Its largest new stake was R1 RCM Inc. Common Stock: 352,500 shares worth $6.53M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 45% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $456K trimmed.

  • DSC Advisors's largest Q3 2022 buy was R1 RCM Inc. Common Stock: 352,500 shares worth $6.53M.
  • DSC Advisors added most to Meta Platforms (Facebook) in Q3 2022, an estimated $581K increase.
  • DSC Advisors's biggest Q3 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $456K.
  • DSC Advisors fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $5.11M.
  • DSC Advisors's ten largest holdings make up 57% of its $97M portfolio in Q3 2022.
  • DSC Advisors opened 11 new positions and closed 27 in Q3 2022.
  • DSC Advisors's portfolio value fell 3% quarter-over-quarter to $97M.

Based on DSC Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.